Bladder

Open Clinical Trials

Atezolizmab

Protocol Number: Alliance – S1605
Phase II Trial of Atezolizumab in BCG-Un-responsive Non-Muscle Invasive Baldder Cancer – OPEN TO ENROLLMENT